Kopran

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE082A01010
  • NSEID: KOPRAN
  • BSEID: 524280
INR
136.60
-3.1 (-2.22%)
BSENSE

Dec 05

BSE+NSE Vol: 10.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 568367,
    "name": "Kopran",
    "stock_name": "Kopran",
    "full_name": "Kopran Ltd",
    "name_url": "stocks-analysis/kopran",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "136.60",
    "chg": -3.1,
    "chgp": "-2.22%",
    "dir": -1,
    "prev_price": "139.70",
    "mcapval": "659.58 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524280,
    "symbol": "KOPRAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE082A01010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "10.53 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kopran-568367-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kopran’s Evaluation Revised Amidst Challenging Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-downgraded-to-strong-sell-by-marketsmojo-amid-weak-financials-and-bearish-technicals-3746328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_mojoScore_3746328.png",
        "date": "2025-12-04 11:08:46",
        "description": "Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial performance and technical outlook. This adjustment follows a series of results that have highlighted persistent operational difficulties and subdued investor interest."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724752.png",
        "date": "2025-11-24 10:42:33",
        "description": "Kopran, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724749.png",
        "date": "2025-11-24 10:42:30",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724763.png",
        "date": "2025-11-24 10:42:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724750.png",
        "date": "2025-11-24 10:42:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724748.png",
        "date": "2025-11-24 10:42:21",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724746",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724746.png",
        "date": "2025-11-24 10:42:16",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum. This development comes despite a broadly positive market environment, with the Sensex trading near its 52-week high."
      },
      {
        "title": "Why is Kopran falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kopran-fallingrising-3722137",
        "imagepath": "",
        "date": "2025-11-22 01:08:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend Against Market Benchmarks</strong></p>\n<p>Kopran’s recent price action reflects a sustained decline that has persisted over multiple time horizons. Over the past week, the stock has lost 9.45%, while the Sensex benchmark index has gained 0.79%. This divergence is even more pronounced over the last month, with Kopran falling 23.90% compared to the Sensex’s modest 0.95% rise. Year-to-date figures reveal a stark contrast: Kopran is down 39.73%, whereas the Sensex has advanced 9.08%. Over the last year, the stock has declined 35.41%, while the Sensex has appreciated 10.47%. Even on a three-year basis, Kopran’s performance lags significantly, with a 4.97% loss versus the Sensex’s 39.39% gain. Although the five-year return shows a modest 8.91% increase for Kopran, it pales in ..."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.129 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs129-amid-continued-earnings-pressure-3720782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3720782.png",
        "date": "2025-11-21 11:22:51",
        "description": "Kopran, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.129, marking a significant decline in its stock price. This drop reflects ongoing challenges in the company’s financial performance and market positioning, with the stock trading below all major moving averages and underperforming its sector peers."
      }
    ],
    "total": 251,
    "sid": "568367",
    "stock_news_url": "https://www.marketsmojo.com/news/kopran-568367"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Dec-2025",
      "details": "Results for the Quarter ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "12-Nov-2025",
      "details": "Investor Presentation on Q2 FY 2025-26 results",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "12-Nov-2025",
      "details": "Results for the Quarter ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Dec-2025 | Source : BSE

Results for the Quarter ended September 30 2025

Announcement under Regulation 30 (LODR)-Investor Presentation

12-Nov-2025 | Source : BSE

Investor Presentation on Q2 FY 2025-26 results

Board Meeting Outcome for Outcome Of Board Meeting

12-Nov-2025 | Source : BSE

Results for the Quarter ended September 30 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kopran Ltd has declared 30% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available